Status:

COMPLETED

An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

Lead Sponsor:

Pfizer

Conditions:

Onychomycosis

Tinea Unguium

Eligibility:

All Genders

72-203 years

Phase:

PHASE4

Brief Summary

This was an open-label study to evaluate the safety and pharmacokinetics of tavaborole 5% topical solution in treating distal subungual onychomycosis (a fungal infection) of the toenail in children an...

Detailed Description

This was an open-label study to evaluate the safety, tolerability, and pharmacokinetics of tavaborole 5% topical solution in treating distal subungual onychomycosis (DSO) of the toenail in pediatric s...

Eligibility Criteria

Inclusion

  • males or females, ages \>/= 6 years and \</= 16 years and 11 months
  • clinical diagnosis of distal subungual onychomycosis affecting at least 20% of one of the great toenails (target nail); and with positive KOH and positive culture for T. rubrum or T. mentagrophytes from either great toenail

Exclusion

  • the target toenail has proximal subungual onychomycosis, onychomycosis involving the nail lunula, superficial white onychomycosis, dermatophytoma, exclusively lateral disease, or yellow or brown spikes, or has co-infection with certain fungi or molds
  • anatomic abnormalities of the toes or toenail
  • current or past history of chronic moccasin-type tinea pedis
  • current or past history of psoriasis or lichen planus
  • history of significant chronic fungal disease (other than onychomycosis)
  • diabetes
  • immunodeficiency

Key Trial Info

Start Date :

October 22 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 27 2017

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT03405818

Start Date

October 22 2015

End Date

July 27 2017

Last Update

April 17 2018

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Madera Family Medical Group

Madera, California, United States, 93637

2

Stanford University School of Medicine

Palo Alto, California, United States, 94304

3

MedStar Health Research Institute - MedStar Georgetown University Hospital

Washington D.C., District of Columbia, United States, 20016

4

Doctors Research Network

South Miami, Florida, United States, 33143